Daily injection with frOpn1 in tumors of melanoma-bearing mice resulted in significantly enhanced recruitment of pDCs and especially IFN-β–producing pDCs, compared with scrambled frOpn3, PBS control, and pDC-depleted groups (Fig. 8, a and b). Here, IFNB1 is linked to melanoma.